Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

In two books — one compassionate and scientific, the other angry and polemical — David Kessler and Stuart Gillespie tackle ...

The S&P 500 climbed 0.61% on Wednesday (July 9), driven by gains in tech stocks as Nvidia hit a historic milestone and ...

Nandita Vijayasimha, Bengaluru Monday, July 7, 2025, 08:00 Hrs [IST] ...

Blockbuster weight loss drugs like Ozempic, Wegovy and Mounjaro may slash the risk of a disorder affecting nearly 7million ...

Adding this $4 vegetable to your diet may help you lose weight, prevent high blood sugar levels and brain inflammation, a study suggests.

Millennial model and content creator Kaila Uli is going viral for calling out TikTok’s troubling obsession with the “Y2K ...

Sadly, the evidence shows Harvard has also wrecked the hard sciences.

A recent investigation by a South African environmental group revealed that 43% of schools involved in a water quality ...

A simple oversight could end up costing Danish pharma giant Novo Nordisk A/S (NYSE: NVO) billions in potential losses on its blockbuster weight-loss and diabetes drug, Ozempic.

Patients taking semaglutide, the active ingredient in Ozempic, were less likely to develop Alzheimer’s. Randomized clinical trials are needed to pin down the exact cause of this difference in risk.